Dr. Angela E. Scheuerle, MD is a genetics specialist in Dallas, TX specializing in genetics, general pediatrics, general practice and clinical molecular genetics. She graduated from University of South Florida College of Medicine in 1988 and has 37 years of experience. Dr. Angela E. Scheuerle, MD is affiliated with Texas Health Resources, Children's Health, UT Southwestern Medical Center and Children's Health Specialty Center Dallas Campus.
8160 Walnut Hill Lane Suite 106
Dallas, TX 75231
2350 N Stemmons Freeway Suite F4200
Dallas, TX 75207
1935 Medical District Drive
Dallas, TX 75235
Dr. Angela E. Scheuerle, MD graduated from University of South Florida College of Medicine in 1988. She completed residency at Childrens Hospital Medical Center of Cincinnati. She is certified by the American Board of Medical Genetics and Genomics and has a state license in Texas.
Medical School: University of South Florida College of Medicine (1988)
Residency: Childrens Hospital Medical Center of Cincinnati (1991)
Board Certification: American Board of Medical Genetics and Genomics
Licensed In: Texas
Dr. Angela E. Scheuerle, MD is associated with these hospitals and organizations:
Dr. Angela E. Scheuerle, MD has an average of 1.0 out of 5 stars based on 2 ratings. We collect ratings and reviews of Dr. Angela E. Scheuerle, MD from all over the web to help you find the right in Dallas, TX.
Awful experience. Dr. Scheuerle was extremely dismissive of my concerns as parent and the information my 16yo was providing her with about her own health. She did not ask permission to touch my teen or look under clothing. She had her mind made up before she even walked in the room and completely blew us both off. She was using a standard evaluation form but did not even ask half the questions on it which were very relative and things my child struggles with daily. She offered a referral to PT and Pain Management and sent us on our way. We never received those and have had ZERO follow up communication.
Worst experience. She would not listen to me as a mother. She was very rude and combative. No bedside manners. Do not go see her. No compassion. Hard. Unfeeling. I could keep going on. I walked out of the room.
These charts describe general payments received by Dr. Angela E. Scheuerle, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
UCB SA |
$37,625
$37,625 |
|||||
---|---|---|---|---|---|---|
Genentech, Inc. |
$25,309
XOLAIR $25,309 |
|||||
Lupin Inc. |
$20,267
GENERIC $20,267 |
|||||
UCB Biosciences Inc. |
$18,120
Cimzia $3,601 |
$14,518 |
||||
ViiV Healthcare Company |
$12,217
TIVICAY $3,250 |
$8,967 |
||||
Other |
$63,304
Tresiba $5,500 |
XOLAIR $5,198 |
Nevirapine $5,046 |
Invirase $4,570 |
Norvir $3,242 |
Other $39,748 |
Consulting Fee | $159,540 |
---|---|
Travel and Lodging | $8,927 |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,054 |
Food and Beverage | $1,550 |
Grant | $1,452 |
Other | $320 |
Dr. Angela E. Scheuerle, MD has received 169 research payments totaling $71,030.
Dr. Angela Scheuerle is a specialist in clinical molecular genetics, general practice, and general pediatrics in Dallas, TX. In addition to English, Dr. Scheuerle speaks Spanish. These areas are among her clinical interests: cleft lip and palate and ehlers-danlos syndrome. She is professionally affiliated with Children's Health, Texas Health Dallas, and UT Southwestern Medical Center. Dr. Scheuerle attended the University of South Florida (USF) College of Medicine and then went on to complete her residency at Cincinnati Children's Hospital Medical Center, a hospital affiliated with Baylor College of Medicine, and a hospital affiliated with the University of Manitoba. Distinctions awarded to Dr. Scheuerle include: D Magazine Best Doctor; D Magazine Best Pediatric Specialist; and National Birth Defect Prevention Network Phi Beta Kappa. She welcomes new patients at her office inDallas, TX as reported by Yext.